@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311093627 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-09"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL2311093627" ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "40" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "9.345 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Irbesartan" ;
            mbo:ch_compound_class "Pharmaceutical" ;
            mbo:ch_exact_mass 4.282325e+02 ;
            rdfs:seeAlso cas:138402-11-6 ;
            schema:inChI "InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)" ;
            schema:inChIKey inchikey:YOSHYTLCDANDAN-UHFFFAOYSA-N ;
            schema:molecularFormula "C25H28N6O" ;
            schema:name "Irbesartan" ;
            schema:smiles "CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5n[nH]nn5" ] ;
    mbo:has_peak [ mbo:intensity 4.04e+01 ;
            mbo:mz 8.40834e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 5.45e+01 ;
            mbo:mz 1.900653e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 72 ],
        [ mbo:intensity 2.16e+01 ;
            mbo:mz 1.910732e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 28 ],
        [ mbo:intensity 9.84e+01 ;
            mbo:mz 1.920767e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 130 ],
        [ mbo:intensity 1.69e+02 ;
            mbo:mz 1.951496e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 223 ],
        [ mbo:intensity 5.95e+01 ;
            mbo:mz 2.050763e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 78 ],
        [ mbo:intensity 1.251e+02 ;
            mbo:mz 2.060844e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 165 ],
        [ mbo:intensity 7.574e+02 ;
            mbo:mz 2.070915e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.79e+01 ;
            mbo:mz 2.350981e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 7.02e+01 ;
            mbo:mz 3.862236e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 93 ],
        [ mbo:intensity 1.99e+01 ;
            mbo:mz 4.012346e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 26 ],
        [ mbo:intensity 8.8e+00 ;
            mbo:mz 1.520622e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 8.78e+01 ;
            mbo:mz 4.292407e+02 ;
            mbo:peak_sequential_number 20 ;
            mbo:relative_intensity 116 ],
        [ mbo:intensity 1.79e+01 ;
            mbo:mz 1.530698e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 1.17e+01 ;
            mbo:mz 1.650699e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 15 ],
        [ mbo:intensity 7.8e+00 ;
            mbo:mz 1.670731e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 2.38e+01 ;
            mbo:mz 1.671543e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 31 ],
        [ mbo:intensity 4.4e+01 ;
            mbo:mz 1.780662e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 58 ],
        [ mbo:intensity 3.16e+01 ;
            mbo:mz 1.79073e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 42 ],
        [ mbo:intensity 1.224e+02 ;
            mbo:mz 1.800811e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 161 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz_value "429.2397"^^xsd:float ;
            mbo:precursor_type_value "[M+H]+" ] ;
    mbo:pk_num_peak 20 ;
    mbo:pk_splash "splash10-0a4i-0590100000-5dee8d7468557554c5da" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "Irbesartan; LC-ESI-QTOF; MS2; 40 V" .

